Monoclonal antibody treatments have many challenges — Narval is fixing them

Monoclonal antibodies are the building blocks of some of the most important medical treatments in the world. But they have limitations. For example, the

Related Keywords

India ,Mexico ,Germany ,China ,United States ,German ,Alexei Licea ,Nabla Bio ,Alejandro Nuno ,Jose Luis Nuno ,European Union ,Boehringer Ingelheim ,Luis Nuno ,Techcrunch Disrupt ,Startup Battlefield ,